Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells
- PMID: 19759338
- PMCID: PMC2777764
- DOI: 10.1152/ajpregu.00227.2009
Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells
Abstract
Skeletal muscle produces a myriad of mitogenic factors possessing cardiovascular regulatory effects that can be explored for cardiac repair. Given the reported findings that VEGF may modulate muscle regeneration, we investigated the therapeutic effects of chronic injections of low doses of human recombinant VEGF-A(165) (0.1-1 microg/kg) into the dystrophic hamstring muscle in a hereditary hamster model of heart failure and muscular dystrophy. In vitro, VEGF stimulated proliferation, migration, and growth factor production of cultured C2C12 skeletal myocytes. VEGF also induced production of HGF, IGF2, and VEGF by skeletal muscle. Analysis of skeletal muscle revealed an increase in myocyte nuclear [531 +/- 12 VEGF 1 microg/kg vs. 364 +/- 19 for saline (number/mm(2)) saline] and capillary [591 +/- 80 VEGF 1 microg/kg vs. 342 +/- 21 for saline (number/mm(2))] densities. Skeletal muscle analysis revealed an increase in Ki67(+) nuclei in the VEGF 1 microg/kg group compared with saline. In addition, VEGF mobilized c-kit(+), CD31(+), and CXCR4(+) progenitor cells. Mobilization of progenitor cells was consistent with higher SDF-1 concentrations found in hamstring, plasma, and heart in the VEGF group. Echocardiogram analysis demonstrated improvement in left ventricular ejection fraction (0.60 +/- 0.02 VEGF 1 microg/kg vs. 0.45 +/- 0.01 mm for saline) and an attenuation in ventricular dilation [5.59 +/- 0.12 VEGF 1 microg/kg vs. 6.03 +/- 0.09 for saline (mm)] 5 wk after initiating therapy. Hearts exhibited higher cardiomyocyte nuclear [845 +/- 22 VEGF 1 microg/kg vs. 519 +/- 40 for saline (number/mm(2))] and capillary [2,159 +/- 119 VEGF 1 microg/kg vs. 1,590 +/- 66 for saline (number/mm(2))] densities. Myocardial analysis revealed approximately 2.5 fold increase in Ki67+ cells and approximately 2.8-fold increase in c-kit(+) cells in the VEGF group, which provides evidence for cardiomyocyte regeneration and progenitor cell expansion. This study provides novel evidence of a salutary effect of VEGF in the cardiomyopathic hamster via induction of myogenic growth factor production by skeletal muscle and mobilization of progenitor cells, which resulted in attenuation of cardiomyopathy and repair of the heart.
Figures
Similar articles
-
Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair.Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2422-32. doi: 10.1152/ajpheart.00343.2011. Epub 2011 Sep 30. Am J Physiol Heart Circ Physiol. 2011. PMID: 21963833 Free PMC article.
-
Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen.Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1888-97. doi: 10.1152/ajpheart.00186.2009. Epub 2009 Apr 24. Am J Physiol Heart Circ Physiol. 2009. PMID: 19395555 Free PMC article.
-
Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H605-18. doi: 10.1152/ajpheart.00366.2012. Epub 2012 Jun 29. Am J Physiol Heart Circ Physiol. 2012. PMID: 22752632 Free PMC article.
-
Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair.Stem Cells Transl Med. 2014 Feb;3(2):183-93. doi: 10.5966/sctm.2013-0122. Epub 2013 Dec 26. Stem Cells Transl Med. 2014. PMID: 24371329 Free PMC article. Review.
-
c-kit(+) cells: the tell-tale heart of cardiac regeneration?Cell Mol Life Sci. 2015 May;72(9):1725-40. doi: 10.1007/s00018-014-1832-8. Epub 2015 Jan 10. Cell Mol Life Sci. 2015. PMID: 25575564 Free PMC article. Review.
Cited by
-
Bi-functional KIT-PR1P peptides combine with VEGF to protect ischemic kidney in rats by targeting to Kim-1.Regen Ther. 2023 Dec 28;25:162-173. doi: 10.1016/j.reth.2023.12.014. eCollection 2024 Mar. Regen Ther. 2023. PMID: 38178930 Free PMC article.
-
Cardiac epigenetic changes in VEGF signaling genes associate with myocardial microvascular rarefaction in experimental chronic kidney disease.Am J Physiol Heart Circ Physiol. 2023 Jan 1;324(1):H14-H25. doi: 10.1152/ajpheart.00522.2022. Epub 2022 Nov 11. Am J Physiol Heart Circ Physiol. 2023. PMID: 36367693 Free PMC article.
-
The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster.PLoS One. 2018 Dec 5;13(12):e0202838. doi: 10.1371/journal.pone.0202838. eCollection 2018. PLoS One. 2018. PMID: 30517097 Free PMC article.
-
VEGF therapy for the kidney: emerging strategies.Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F747-F751. doi: 10.1152/ajprenal.00617.2017. Epub 2018 Feb 14. Am J Physiol Renal Physiol. 2018. PMID: 29442546 Free PMC article. Review.
-
Elevating VEGF-A and PDGF-BB secretion by salidroside enhances neoangiogenesis in diabetic hind-limb ischemia.Oncotarget. 2017 Oct 13;8(57):97187-97205. doi: 10.18632/oncotarget.21907. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228603 Free PMC article.
References
-
- Abraham D, Hofbauer R, Schafer R, Blumer R, Paulus P, Miksovsky A, Traxler H, Kocher A, Aharinejad S. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 87: 644–647, 2000 - PubMed
-
- Aperghis M, Velloso CP, Hameed M, Brothwood T, Bradley L, Bouloux PM, Harridge SD, Goldspink G. Serum IGF-I levels and IGF-I gene splicing in muscle of healthy young males receiving rhGH. Growth Horm IGF Res 19: 61–67, 2009 - PubMed
-
- Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 10: 844–854, 2004 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
